6872.TWO NaviFUS Corp.

Healthcare Medical Devices Taiwan OTC Exchange
17.05 TWD
Close of Nov 6, 2026
13.80 27.05
Market cap
TWD 1.21B
P/E
-
P/B
2.60x
ROE
-29.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 6872.TWO undervalued?

Graham number

The Graham number of NaviFUS Corp. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NaviFUS Corp. fundamental analysis

No fundamental analysis for NaviFUS Corp. yet.

NaviFUS Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NaviFUS Corp.

NaviFUS Corp., a medical device company, develops and sells focused ultrasound (FUS) solutions for the unmet needs in neuromedicine in Taiwan. The company develops NaviFUS, a neuronavigator-guided transcranial FUS system that delivers focal energy into deep tissues in the brain, as well as is used in various clinical applications, such as drug delivery, neuromodulation, immuno-stimulation, and others. It also develops NAVIRFA, a navigation system that uses optical 3D surgica…

Full company profile